Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Taketoshi Okubo"'
Autor:
Mizuho Honda, Sakae Nakamura, Tokiko Shindo, Taketoshi Okubo, Sachiko Fushimi, Tomoko Yamanaka
Publikováno v:
Journal of Information Processing and Management. 57:157-169
Autor:
Dai Nozawa, Shigeru Okuyama, Shigeyuki Chaki, Taketoshi Okubo, Atsuro Nakazato, Takaaki Ishii
Publikováno v:
Chemical and Pharmaceutical Bulletin. 55:1044-1050
While examining antagonists of the melanocortin-4 receptor (MC4 receptor), we found that compound 12b, containing a diphenylmethyl moiety, had a relatively high affinity for the MC4 receptor. When diphenylmethyl analogues were further examined, compo
Publikováno v:
Chemical and Pharmaceutical Bulletin. 55:1232-1239
In the present study, conducted to explore potent and small molecular melanocortin-4 (MC4) receptor ligands, we found that tripeptide 3a, containing a D-Phe-Arg-2-Nal (Nal; naphthylalanine) sequence, exhibited a moderate affinity for the MC4 receptor
Autor:
Hideo Tanaka, Toshihito Kumagai, Kazuyuki Tomisawa, Atsuro Nakazato, Shigeyuki Chaki, Shigeru Okuyama, Taketoshi Okubo
Publikováno v:
Bioorganic & Medicinal Chemistry. 8:1183-1193
Recently, various non-peptide corticotropin-releasing factor1 (CRF1) receptor antagonists have been reported. Structure-affinity relationships (SARs) of non-peptide CRF antagonists suggest that such antagonists can be constructed of three units: a hy
Autor:
Masashi Nagamine, Shigeru Okuyama, Takeo Funakoshi, Shigeyuki Chaki, Ryoko Yoshikawa, Taketoshi Okubo, Kazuyuki Tomisawa, Atsuro Nakazato
Publikováno v:
European Journal of Pharmacology. 371:197-204
Here, we investigated the binding characteristics of [ 3 H ]N-(2,5-dimethoxybenzyl)-N-(5-fluoro-2-phenoxyphenyl)acetamide ([ 3 H ]DAA1106), a potent and selective ligand for peripheral benzodiazepine receptors, in mitochondrial fractions of the rat b
Autor:
Kazuyuki Tomisawa, Yuichi Oshida, Shigeyuki Chaki, Toshihito Kumagai, Yuko Hamajima, Atsuro Nakazato, Taketoshi Okubo, Yoko Ikeda, Shigeru Okuyama
Publikováno v:
European Journal of Pharmacology. 371:205-211
We investigated pharmacological properties of CRA1000 (2-(N-(2-methylthio-4-isopropylphenyl)-N-ethylamino-4-(4-(3-fluorophenyl)-1,2,3,6-tetrahydropyridin-1-yl)-6-methylpyrimidine) and CRA1001 (2-(N-(2-bromo-4-isopropylphenyl)-N-ethylamino-4-(4-(3-flu
Autor:
Taketoshi Okubo, Shigeru Okuyama, Shigeyuki Chaki, Kazuyuki Tomisawa, Ryoko Yoshikawa, Masasi Nagamine, Atsuro Nakazato, Yoshiko Suzuki, Shin-ichi Ogawa
Publikováno v:
Life Sciences. 64:1455-1464
Receptor binding and behavioral profiles of N-(4-chloro-2-phenoxyphenyl)-N-(2-isopropoxybenzyl)acetamide (DAA1097) and N-(2,5-dimethoxybenzyl)-N-(5-fluoro-2-phenoxyphenyl)acetamide (DAA1106), novel, selective agonists for the peripheral benzocliazepi
Autor:
Dai Nozawa, Shigeru Okuyama, Taketoshi Okubo, Kazuaki Takamori, Atsuro Nakazato, Takaaki Ishii, Shigeyuki Chaki
Publikováno v:
Bioorganicmedicinal chemistry. 15(6)
In the present study, we found that a novel piperazine compound, 11a, showed a moderate affinity (IC50 = 333 nM) for the MC4 receptor. We developed the new type of piperazine compounds and found that mono-piperazine 11b exhibited a high-affinity (IC5
Structure-activity relationships of novel piperazines as antagonists for the melanocortin-4 receptor
Autor:
Hiroyuki Kakinuma, Dai Nozawa, Taketoshi Okubo, Shigeru Okuyama, Atsuro Nakazato, Shigeyuki Chaki, Takaaki Ishii
Publikováno v:
Bioorganicmedicinal chemistry. 15(5)
During the investigation of antagonists for the MC4 receptor, we found that 10ab having a naphthyl group showed almost the same binding affinity for the MC4 receptor as that of the lead compound 1 with a benzoyl group. We also developed a new type of
Autor:
Taketoshi Okubo, Takeo Funakoshi, Shigeyuki Chaki, Shigeru Okuyama, Atsuro Nakazato, Toshiharu Shimazaki, Shin-ichi Ogawa, Yuichi Oshida
Publikováno v:
Pharmacology, biochemistry, and behavior. 82(4)
In the present study, we examined the anxiolytic and antidepressant effects of MCL0042, a novel compound showing activity in both MC4 receptor antagonism and serotonin transporter inhibition. MCL0042 showed relatively high affinity for the MC4 recept